Several years ago we reported that liposomal all- trans retinoic acid (L-ATRA) used alone might cure some patients with untreated acute promyelocytic leukemia (APL).[1][1],[2][2] The median follow-up was 1.5 years from complete remission (CR) date. Because the risk of relapse does not decrease
No takes yet. Share an insight, caveat, or question.
Estey et al. (2005) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: